The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi
Open Access
- 29 January 2010
- journal article
- Published by Elsevier BV in Molecular Cell
- Vol. 37 (2), 159-171
- https://doi.org/10.1016/j.molcel.2009.12.023
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1Proceedings of the National Academy of Sciences of the United States of America, 2009
- Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiationNucleic Acids Research, 2008
- Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney DevelopmentOnline Journal of Public Health Informatics, 2007
- Proteome-wide Identification of HtrA2/Omi SubstratesJournal of Proteome Research, 2007
- Protocol for the fast chromatin immunoprecipitation (ChIP) methodNature Protocols, 2006
- Insights into the physiological role of WT1 from studies of genetically modified micePhysiological Genomics, 2004
- The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomesHuman Molecular Genetics, 2003
- Characterization of a Novel and Specific Inhibitor for the Pro-apoptotic Protease Omi/HtrA2Online Journal of Public Health Informatics, 2003
- Par4 is a coactivator for a splice isoform–specific transcriptional activation domain in WT1Genes & Development, 2001
- Autoregulation of the human WT1 gene promoterFEBS Letters, 1994